U.S. flag

An official website of the United States government

NM_000255.4(MMUT):c.257C>T (p.Pro86Leu) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001376596.5

Allele description [Variation Report for NM_000255.4(MMUT):c.257C>T (p.Pro86Leu)]

NM_000255.4(MMUT):c.257C>T (p.Pro86Leu)

Gene:
MMUT:methylmalonyl-CoA mutase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p12.3
Genomic location:
Preferred name:
NM_000255.4(MMUT):c.257C>T (p.Pro86Leu)
HGVS:
  • NC_000006.12:g.49459210G>A
  • NG_007100.1:g.8930C>T
  • NM_000255.4:c.257C>TMANE SELECT
  • NP_000246.2:p.Pro86Leu
  • NC_000006.11:g.49426923G>A
  • NM_000255.3:c.257C>T
Protein change:
P86L
Links:
dbSNP: rs769348060
NCBI 1000 Genomes Browser:
rs769348060
Molecular consequence:
  • NM_000255.4:c.257C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001237344Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 20, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype.

Worgan LC, Niles K, Tirone JC, Hofmann A, Verner A, Sammak A, Kucic T, Lepage P, Rosenblatt DS.

Hum Mutat. 2006 Jan;27(1):31-43.

PubMed [citation]
PMID:
16281286

Asymptomatic methylmalonic acidemia in a homozygous MUT mutation (p.P86L).

Underhill HR, Hahn SH, Hale SL, Merritt JL 2nd.

Pediatr Int. 2013 Dec;55(6):e156-8. doi: 10.1111/ped.12195.

PubMed [citation]
PMID:
24330302
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001237344.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 86 of the MUT protein (p.Pro86Leu). This variant is present in population databases (rs769348060, gnomAD 0.01%). This missense change has been observed in individual(s) with methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency (PMID: 16281286, 24330302, 27233228). ClinVar contains an entry for this variant (Variation ID: 553773). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MUT protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024